Ann: Nuheara extends research into Autism Spectrum Disorder, page-24

The other potential benefit of this announcement is that it makes a nuheara a more attractive investment for funds that invest in the medtech sector...nuheara is now helping people with hearing loss and auditory sensory problems and now autism...nuheara needs quality, sticky funds to buy on market to soak up all the traders and game-players.

Go on, Justin, go knock on doors of the 10 or so medtech funds out there...

If they happily invest in all the dodgy shit out there in biotech and medtech land, they will certainly consider investing in Nuheara.

Please appoint a a well-connected director good at this “courting” stuff! You need to improve the quality of your shareholders!